These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8275650)

  • 1. Bezoar formed by fragments of extended-release nifedipine tablets.
    Shepherd MF
    Clin Pharm; 1993 Nov; 12(11):849-52. PubMed ID: 8275650
    [No Abstract]   [Full Text] [Related]  

  • 2. Nifedipine GITS (gastrointestinal therapeutic system) bezoar.
    Prisant LM; Carr AA; Bottini PB; Kaesemeyer WH
    Arch Intern Med; 1991 Sep; 151(9):1868-9. PubMed ID: 1888255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacobezoar in a patient operated on for pyloric stenosis].
    Marín Pozo JF; Soriano Martínez M; Caba Porras I; Rodríguez Torné G; Castelo Luque A
    Farm Hosp; 2004; 28(1):59-63. PubMed ID: 15012180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic medication bezoar from extended-release nifedipine and procainamide.
    Reid T; Rubins JB; Levine J; DeCelles J; Silvis S
    Arch Fam Med; 1995 Aug; 4(8):715-7. PubMed ID: 7620602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe gastrointestinal dysfunction and retention of extended release nifedipine tablets.
    Smitz S; Bonnet V; Delporte JP
    J Am Geriatr Soc; 1998 May; 46(5):656-7. PubMed ID: 9588385
    [No Abstract]   [Full Text] [Related]  

  • 6. Extended-release nifedipine bezoar identified one year after discontinuation.
    Niezabitowski LM; Nguyen BN; Gums JG
    Ann Pharmacother; 2000; 34(7-8):862-4. PubMed ID: 10928396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention of nifedipine extended release tabs in a patient with a colonic stricture.
    Georgopoulos S; Gerdes H
    Am J Gastroenterol; 1995 Dec; 90(12):2224-6. PubMed ID: 8540522
    [No Abstract]   [Full Text] [Related]  

  • 8. Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine.
    Wells CD; Luckritz TC; Rady MY; Zornik JM; Leighton JA; Patel BM
    Pharmacotherapy; 2006 Dec; 26(12):1802-5. PubMed ID: 17125441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk in esophageal obstruction with slow-release medications.
    Simko V; Joseph D; Michael S
    J Assoc Acad Minor Phys; 1997; 8(2):38-42. PubMed ID: 9167415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin.
    Chowdary KP; Kamalakara RG
    Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A rare case of nifedipine bezoar].
    Jarry J; Sassoust G
    Presse Med; 2008 Mar; 37(3 Pt 1):428-30. PubMed ID: 18164899
    [No Abstract]   [Full Text] [Related]  

  • 12. Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy.
    Sawada T; Kondo H; Nakashima H; Sako K; Hayashi M
    Int J Pharm; 2004 Aug; 280(1-2):103-11. PubMed ID: 15265551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GITS--one more dosage form of nifedipine.
    Turakhia DP
    J Assoc Physicians India; 1990 Jun; 38(6):453-4. PubMed ID: 2384476
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preparation of nifidipine pulsatile release tablets].
    Zhang Y; Zhang ZR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):261-3. PubMed ID: 15071935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine gastrointestinal therapeutic system (GITS) as an alternative to slow-release for tocolysis--tolerance and pharmacokinetic profile.
    Juon AM; Kühn-Velten WN; Burkhardt T; Krähenmann F; Zimmermann R; von Mandach U
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):27-32. PubMed ID: 18394772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The long-term effect of nifedipine (control release tablets) in patients with chronic obstructive pulmonary disease and cor pulmonale].
    Cheng X; Yao Z; Li Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Apr; 20(2):84-7. PubMed ID: 10072830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis.
    Nakayama J; Koga T; Furue M
    Eur J Dermatol; 1998 Dec; 8(8):563-8. PubMed ID: 9889429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioequivalence of nifedipine sustained-release formulations in comparison to standard preparations in solid state].
    Herrmann R
    Arzneimittelforschung; 1996 Jan; 46(1):28-34. PubMed ID: 8821514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.